sepsis and the kidney.pdf - SASSiT
sepsis and the kidney.pdf - SASSiT
sepsis and the kidney.pdf - SASSiT
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
214<br />
klenzak & himmelfarb<br />
in <strong>the</strong> setting of hyperdynamic <strong>sepsis</strong>. Although <strong>the</strong> role of hypoperfusion needs<br />
elucidation in <strong>the</strong> setting of <strong>sepsis</strong>, <strong>the</strong>se studies certainly support <strong>the</strong> hypo<strong>the</strong>sis<br />
that mediators of cellular injury, ra<strong>the</strong>r than lack of blood, play a larger role in <strong>the</strong><br />
pathophysiology of ARF [6].<br />
Vasopressors <strong>and</strong> acute renal failure<br />
In <strong>the</strong> setting of hypodynamic septic shock, compensatory increases in<br />
systemic vascular resistance become disabled, leading to pressor desensitivity<br />
<strong>and</strong> refractory hypotension without local autoregulation of <strong>the</strong> vital organs.<br />
Clinical concerns regarding <strong>the</strong> use of vasopressor <strong>the</strong>rapies, which are known<br />
to induce vasoconstriction in <strong>the</strong> setting of ARF, are set aside by <strong>the</strong> supremacy<br />
of increasing systemic blood pressure to levels that continue to perfuse <strong>the</strong><br />
remainder of <strong>the</strong> vital organs. Norepinephrine infusion may, in fact, increase<br />
RBF. Several animal studies have demonstrated increases in RBF with <strong>the</strong> use of<br />
norepinephrine infusion [7–12]. Recent work by Di et al [13] demonstrated that<br />
norepinephrine infusion in septic sheep induced an increase in RBF, countering<br />
concern that vasoconstrictors worsen blood delivery to <strong>the</strong> renal parenchyma in<br />
<strong>the</strong> setting of vasodilatory shock.<br />
Nitric oxide synthase<br />
In contrast, in hyperdynamic shock RBF is preserved, with apparent<br />
redistribution of flow from cortex to medulla, maintaining oxygen delivery to<br />
<strong>the</strong> most vulnerable portions of <strong>the</strong> renal parenchyma, while also decreasing<br />
<strong>the</strong> work of <strong>the</strong> tubules. This redistribution of blood flow coincides with an increase<br />
in nitric oxide (NO) in <strong>the</strong> medulla [14]. Inducible NO synthase (iNOS)<br />
can be expressed locally, in glomerular mesangial cells <strong>and</strong> endo<strong>the</strong>lial cells,<br />
after stimulation with proinflammatory cytokines, including tumor necrosis factor<br />
(TNF) <strong>and</strong> interleukin (IL)-1, <strong>and</strong> endotoxin [15]. Nonselective or selective<br />
blockade of NOS decreases RBF while increasing mean arterial pressure. This<br />
suggests that iNOS plays a role in maintaining RBF in <strong>the</strong> setting of shock<br />
through its vasodilatory effects at <strong>the</strong> afferent arteriole. Despite increases in<br />
iNOS, renal vasoconstriction can be seen in <strong>the</strong> setting of systemic vasodilation.<br />
The mechanism of vasodilation by NO is dependent on <strong>the</strong> syn<strong>the</strong>sis of cyclic<br />
guanosine monophosphate by soluble guanylate cyclase. Studies of lipopolysaccharide<br />
(LPS) stimulation in mice leading to shock <strong>and</strong> ARF have demonstrated<br />
a decrease in cyclic guanosine monophosphate to basal levels at 24 hours,<br />
despite an early rise in <strong>and</strong> sustained iNOS levels, suggesting that desensitization<br />
of soluble guanylate cyclase results in loss of regulatory vasodilation in <strong>the</strong> <strong>kidney</strong><br />
[16]. NOS inhibition in animal models of endotoxemia results in glomerular<br />
thrombosis <strong>and</strong> declines in creatinine clearance. The glomerular thrombosis<br />
in <strong>the</strong> setting of NOS inhibition seems related to <strong>the</strong> antithrombotic qualities of